Page last updated: 2024-10-30

loperamide and Rectal Neoplasms

loperamide has been researched along with Rectal Neoplasms in 3 studies

Loperamide: One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally.
loperamide : A synthetic piperidine derivative, effective against diarrhoea resulting from gastroenteritis or inflammatory bowel disease.

Rectal Neoplasms: Tumors or cancer of the RECTUM.

Research Excerpts

ExcerptRelevanceReference
"Forty-two rectal carcinoma (T(3-4)N(0-2)M(0)) patients with grade 2 or 3 diarrhea refractory to loperamide were enrolled to receive octreotide."9.12Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma. ( Karaoglu, A; Topkan, E, 2006)
"Forty-two rectal carcinoma (T(3-4)N(0-2)M(0)) patients with grade 2 or 3 diarrhea refractory to loperamide were enrolled to receive octreotide."5.12Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma. ( Karaoglu, A; Topkan, E, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McKenna, NP1
Beppu, N1
Fumihiko, K1
Hiroshi, D1
Norihiko, K1
Matsubara, N1
Tomita, N1
Yanagi, H1
Yamanaka, N1
Topkan, E1
Karaoglu, A1

Trials

1 trial available for loperamide and Rectal Neoplasms

ArticleYear
Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
    Oncology, 2006, Volume: 71, Issue:5-6

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Combined Modality Therapy; Diarrhea; Dose-Response Re

2006

Other Studies

2 other studies available for loperamide and Rectal Neoplasms

ArticleYear
Low Anterior Resection Syndrome.
    Diseases of the colon and rectum, 2019, Volume: 62, Issue:12

    Topics: Adenocarcinoma; Aged; Chemotherapy, Adjuvant; Fecal Incontinence; Female; Humans; Ileostomy; Loperam

2019
Functional Outcomes of Patients Treated with Intensive Medications for Bowel and Pain Control for Low-Lying Rectal Cancer Who Received Preoperative Chemoradiotherapy.
    Digestive surgery, 2016, Volume: 33, Issue:5

    Topics: Acrylic Resins; Aged; Analgesics, Opioid; Anastomosis, Surgical; Antidiarrheals; Chemoradiotherapy,

2016